Form D · Other Health Care
Foresee Medical, Inc.
San Diego, CA · CIK 0001719442
Offering snapshot reported Oct 30, 2025 · SEC filing
- Reported sold
- $1.6M Offering amount: $1.71M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 21, 2025 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$1,499,999 → $1,599,999
- Reported investors1 → 2
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 30, 2025 | Amendment | $1,599,999 | $100,000vs Apr 4, 2025 | 2 | SEC filing |
| Oct 30, 2025 | Amendment | $1,999,992 | $349,998vs Apr 18, 2025 | 26 | SEC filing |
| Apr 18, 2025 | Amendment | $1,649,994 | $699,997vs Mar 14, 2025 | 21 | SEC filing |
| Apr 4, 2025 | Initial | $1,499,999 | No comparison | 1 | SEC filing |
| Mar 14, 2025 | Initial | $949,997 | No comparison | 10 | SEC filing |
| Jan 10, 2025 | Amendment | $4,949,992 | $499,998vs Dec 27, 2024 | 20 | SEC filing |
| Dec 27, 2024 | Amendment | $4,449,994 | $275,000vs Dec 16, 2024 | 18 | SEC filing |
| Dec 16, 2024 | Amendment | $4,174,994 | $2,724,997vs May 17, 2024 | 16 | SEC filing |
| May 17, 2024 | Amendment | $1,449,997 | $199,999vs Apr 29, 2024 | 9 | SEC filing |
| Apr 29, 2024 | Initial | $1,249,998 | No comparison | 7 | SEC filing |
| Feb 16, 2024 | Initial | $499,999 | No comparison | 1 | SEC filing |
| Apr 10, 2023 | Initial | $3,999,999 | No comparison | 1 | SEC filing |
| Apr 10, 2023 | Amendment | $9,539,991 | $924,999vs Dec 20, 2022 | 30 | SEC filing |
| Dec 20, 2022 | Amendment | $8,614,992 | $1,874,999vs Jun 29, 2022 | 27 | SEC filing |
| Jun 29, 2022 | Amendment | $6,739,993 | $1,000,000vs May 26, 2022 | 22 | SEC filing |
| May 26, 2022 | Amendment | $5,739,993 | $999,999vs Apr 22, 2022 | 22 | SEC filing |
| Apr 22, 2022 | Amendment | $4,739,994 | $3,649,998vs Mar 3, 2022 | 21 | SEC filing |
| Mar 3, 2022 | Amendment | $1,089,996 | $389,998vs Feb 2, 2022 | 13 | SEC filing |
| Feb 2, 2022 | Initial | $699,998 | No comparison | 4 | SEC filing |
| Jul 13, 2021 | Amendment | $10,300,011 | No comparison | Not reported | SEC filing |
| Apr 14, 2021 | Amendment | $8,400,013 | No comparison | Not reported | SEC filing |
| Mar 4, 2021 | Amendment | $7,380,014 | $1,645,018vs Jan 15, 2021 | 25 | SEC filing |
| Jan 15, 2021 | Amendment | $5,734,996 | $724,999vs Nov 20, 2020 | 15 | SEC filing |
| Nov 20, 2020 | Amendment | $5,009,997 | $2,009,998vs Aug 11, 2020 | 11 | SEC filing |
| Aug 11, 2020 | Amendment | $2,999,999 | $1,000,000vs Apr 6, 2020 | 2 | SEC filing |
| Apr 6, 2020 | Initial | $1,999,999 | No comparison | 1 | SEC filing |
| Dec 5, 2019 | Amendment | $9,999,991 | $1,069,998vs Jun 27, 2019 | 34 | SEC filing |
| Jun 27, 2019 | Amendment | $8,929,993 | $1,504,997vs Mar 13, 2019 | 27 | SEC filing |
| Mar 13, 2019 | Amendment | $7,424,996 | $1,374,999vs Dec 20, 2018 | 16 | SEC filing |
| Dec 20, 2018 | Amendment | $6,049,997 | $2,249,999vs Sep 21, 2018 | 12 | SEC filing |
| Sep 21, 2018 | Initial | $3,799,998 | No comparison | 6 | SEC filing |
| Oct 12, 2017 | Initial | $3,000,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-543017
Source: Form D, filed Oct 30, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jonathan Flam | Director, Executive |
| Seth Flam | Director, Executive |
| Byron Georgiou | Director |
| Sol Lizerbram | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
11622 El Camino Real Suite 100
San Diego, CA, 92130
San Diego, CA, 92130